Your browser doesn't support javascript.
Role of the PD-1 and PD-L1 axis in COVID-19.
R Bonam, Srinivasa; Hu, Haitao; Bayry, Jagadeesh.
  • R Bonam S; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Hu H; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Bayry J; Institute for Human Infections & Immunity, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
Future Microbiol ; 17: 985-988, 2022 09.
Article in English | MEDLINE | ID: covidwho-2141469
ABSTRACT
Tweetable abstract Severe COVID-19 patients display dysregulated expression of checkpoint molecules PD-1 and its ligand PD-L1, suggesting that these checkpoint molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Future Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: Fmb-2022-0103

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Future Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: Fmb-2022-0103